Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Taiwan foreign minister announces medical donations to Eswatini
04/26/2025 06:46 PM - Society
Kaohsiung daycare center ordered to shut down over abuse allegations
04/26/2025 06:07 PM - Business
Business sentiment among manufacturers weakens amid Trump tariffs
04/26/2025 05:12 PM - Business
S&P affirms Taiwan's long-term rating at 'AA+'; outlook stable
04/26/2025 04:15 PM - Society
4 released on bail after questioning for insider trading
04/26/2025 04:00 PM